Clinical outcomes with ciltacabtagene autoleucel among patients with relapsed/refractory multiple myeloma after four or more prior lines of therapy overall and among subgroups based on age, frailty, and CRAB symptoms
Doris K Hansen, Omar Castañeda Puglianini, Ariel Grajales‐Cruz, Saurabh P. Nagar et autres
1 citationCurrent Medical Research and Opinion